DIABETIC NEPHROPATHY

This adverse event was reported 2203 times

These drugs are most commonly taken by patients reporting DIABETIC NEPHROPATHY:

# Drug Count
0 LANSOPRAZOLE 662
1 OMEPRAZOLE MAGNESIUM 554
2 ESOMEPRAZOLE MAGNESIUM 428
3 OMEPRAZOLE 380
4 PANTOPRAZOLE 289
5 FUROSEMIDE 209
6 METFORMIN 201
7 ESOMEPRAZOLE 194
8 INSULIN GLARGINE 190
9 ASPIRIN 189
See all common drugs associated with DIABETIC NEPHROPATHY

DIABETIC NEPHROPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ZIPRASIDONE 30 0.0083
1 HUMAN INSULIN 34 0.0047
2 OMEPRAZOLE AND SODIUM BICARBONATE 12 0.0043
3 ALISKIREN HEMIFUMARATE 23 0.0038
4 LANSOPRAZOLE 662 0.0037
5 FINERENONE 12 0.0036
6 ACARBOSE 13 0.0033
7 ALOGLIPTIN 8 0.0023
8 CLINDAMYCIN PHOSPHATE 12 0.0022
9 ZIPRASIDONE MESYLATE 30 0.0021
See all drugs enriched for association with DIABETIC NEPHROPATHY

DIABETIC NEPHROPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 alpha-Glucosidase Inhibitor [EPC] 16 0.0033
1 Insulin [EPC] 93 0.0020
2 Provitamin D2 Compound [EPC] 57 0.0019
3 Blood Viscosity Reducer [EPC] 7 0.0016
4 Glinide [EPC] 11 0.0012
5 Proton Pump Inhibitor [EPC] 718 0.0012
6 Dipeptidyl Peptidase 4 Inhibitor [EPC] 35 0.0011
7 Phosphate Binder [EPC] 3 0.0010
8 Vitamin D2 Analog [EPC] 7 0.0010
9 Guanylate Cyclase-C Agonist [EPC] 2 0.0010
See all drug classes enriched for association with DIABETIC NEPHROPATHY